Elsevier

Thrombosis Research

Volume 132, Issue 5, November 2013, Pages 515-519
Thrombosis Research

Regular Article
Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis

https://doi.org/10.1016/j.thromres.2013.08.012Get rights and content

Abstract

Background

Patients with acute deep vein thrombus (DVT) can safely be treated as outpatients. However the role of outpatient treatment in patients diagnosed with a pulmonary embolism (PE) is controversial. We sought to determine the safety of outpatient management of patients with acute symptomatic PE.

Materials and Methods

A systematic literature search strategy was conducted using MEDLINE, EMBASE, the Cochrane Register of Controlled Trials and all EBM Reviews. Pooled proportions for the different outcomes were calculated.

Results

A total of 1258 patients were included in the systematic review. The rate of recurrent venous thromboembolism (VTE) in patients with PE managed as outpatients was 1.47% (95% CI: 0.47 to 3.0%; I2: 65.4%) during the 3 month follow-up period. The rate of fatal PE was 0.47% (95% CI: 0.16 to 1.0%; I2: 0%). The rates of major bleeding and fatal intracranial hemorrhage were 0.81% (95% CI: 0.37 to 1.42%; I2: 0%) and 0.29% (95% CI: 0.06 to 0.68%; I2: 0%), respectively. The overall 3 month mortality rate was 1.58% (95% CI: 0.71 to 2.80%; I2: 45%). The event rates were similar if employing risk stratification models versus using clinical gestalt to select appropriate patients for outpatient management.

Conclusions

Independent of the risk stratification methods used, the rate of adverse events associated with outpatient PE treatment seems low. Based on our systematic review and pooled meta-analysis, low-risk patients with acute PE can safely be treated as outpatients if home circumstances are adequate.

Introduction

Patients with acute deep vein thrombus (DVT) can safely be treated as outpatients [1], [2], [3], [4]. Outpatient treatment of DVT is recommended with grade 1B evidence in the most recent American College of Chest Physicians (ACCP) guidelines [5]. However the ACCP guidelines and other scientific societies have not firmly recommended outpatient therapy for patients with low-risk acute pulmonary embolism (PE) [5], [6]. Clinicians appear reluctant to discharge PE patients due to a perceived lack of high quality data regarding both appropriate patient selection and outcomes with home treatment [7].

Several studies have reported that outpatient management or early discharge of patients with acute PE is safe and effective [8], [9], [10], [11], [12], [13]. Two systematic reviews suggested that patients with acute PE treated as outpatients had low incidences of major bleeding, recurrent venous thromboembolism (VTE), and mortality [14], [15]. However the quality of the included studies was low and subsequent and recent larger observational studies and randomized control trials were not included [8], [11], [16], [17]. More recently, two additional systematic reviews of the outpatient management of acute symptomatic PE were published [18], [19]. However the first review did not include studies of patients with acute PE managed with early discharge and did not perform a meta-analysis [18]. The last review included both retrospective and prospective studies which lower the overall quality of evidence from which the event rates are derived [7], [19].

In this systematic review and meta-analysis we sought to determine the feasibility and safety of outpatient treatment (including early discharge). Furthermore, we attempted to compare the outcome event rates when risk stratification models are applied versus using clinical gestalt to select appropriate patients for outpatient management. Finally, short-term (< 14 days) outcome event rates were evaluated.

Section snippets

Search Strategy

We conducted a systematic literature search to identify potential studies on MEDLINE (1950 to week 4 of June 2012), EMBASE (1980 to end of June 2012), the Cochrane Central Register of Controlled Trials, and all evidence-based medicine reviews (e-Table 1 – online). We also sought publications through a hand-search of potentially relevant journals and International Society of Thrombosis and Haemostasis conference proceedings (2003-2011). We also reviewed the references of included studies and

Results

We identified 1564 citations in our literature search and 16 articles were found to be potentially eligible (Appendix Fig. 1 – online). Five of these articles were then excluded. Three articles because the outcome measures were not reported specifically for patients with acute PE [26], [27], [28] and two because patients had not been managed as outpatients [29], [30]. The remaining 11 studies were included in our systematic review. Eight were prospective cohort studies [8], [11], [12], [13],

Discussion

The results of our systematic review suggest that the short term and long-term (up to 3 months) rates of adverse outcomes are low and patients with low-risk acute symptomatic PE can safely be treated at home. Furthermore, both clinical gestalt and risk stratification models appear to be able to effectively and safely identify low risk patients with acute PE that can be managed as outpatients.

The risk of recurrent VTE, major bleeding episodes and overall mortality after 3 months of follow-up were

Conflict of Interest

All authors have fulfilled the conditions required for authorship and the authors report no potential conflicts of interest.

Funding

Grant Support: SP is a recipient of an American Society of Hematology Trainee Research Award. MC is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada. MR is the recipient of a Career Scientist Award from the Heart and Stroke Foundation of Ontario. PW is a recipient of a Canada Research Chair in Venous Thromboembolism.

Acknowledgements

Authorship

MC and SP designed the study, performed research, collected, analyzed and interpreted data, performed statistical analysis and wrote the manuscript; GL collected, analyzed, and interpreted data, performed statistical analysis and wrote the manuscript; MR analyzed and interpreted the data, performed statistical analysis and wrote the manuscript; PW, MAR and EG analyzed and interpreted the data and provided vital reviews to the manuscript.

References (46)

  • M. Rodríguez -Cerrillo et al.

    A prospective study of the management of non-massive pulmonary embolism in the home

    Eur J Intern Med

    (2009)
  • T. Baglin

    Fifty percent of patients with pulmonary embolism can be treated as outpatients

    J Thromb Haemost

    (2010)
  • B. Park et al.

    Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample

    Chest

    (2009)
  • D. Aujesky et al.

    Short-term prognosis of pulmonary embolism

    J Thromb Haemost

    (2009)
  • A. Squizzato et al.

    Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis

    J Thromb Haemost

    (2012)
  • M.N. Levine et al.

    A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis

    N Engl J Med

    (1996)
  • E. Grau et al.

    Home treatment of deep venous thrombosis with low molecular weight heparin: long term incidence of recurrent venous thromboembolism

    Am J Hematol

    (2001)
  • M.M. Koopman et al.

    Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

    N Engl J Med

    (1996)
  • C. Kearon et al.

    Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    Chest

    (2012)
  • A. Torbicki et al.

    Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)

    Eur Heart J

    (2008)
  • D. Aujesky et al.

    Outpatient treatment of pulmonary embolism

    Swiss Med Wkly

    (2009)
  • C.G. Olsson et al.

    Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy

    Med Sci Monit

    (2006)
  • M. Janjua et al.

    Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review

    Thromb Haemost

    (2008)
  • Cited by (0)

    The research was mainly carried out at The Ottawa Hospital, 501 Smyth Road Ottawa, ON K1H 8L6 Marc Carrier MD, MSc, FRCPC.

    View full text